Green Thumb Industries (GTBIF) Return on Capital Employed (2020 - 2026)
Green Thumb Industries' (GTBIF) quarterly Return on Capital Employed came in at 5.2% in Q1 2026, down 310.0% YoY from 2.47% in Q1 2025, and down 4.26% on a QoQ basis from 5.43% in Q4 2025.
Green Thumb Industries (GTBIF) Return on Capital Employed (2020 - 2026) Analysis & Trends
Green Thumb Industries (GTBIF) has 7 years of Return on Capital Employed data on file, last reported at 5.2% in Q1 2026.
- Quarterly Return on Capital Employed fell 310.0% year-over-year to 5.2% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 5.2% (down 310.0% YoY) and the FY2025 annual result came in at 5.54%, down 402.0% from the prior year.
- Return on Capital Employed eased to 5.2% in Q1 2026, from 5.43% in the prior quarter.
- In the past five years, Return on Capital Employed ranged from a high of 10.29% in Q2 2024 to a low of 3.81% in Q3 2023.
- A 5-year average of 7.47% and a median of 7.8% in 2023 frame the typical range for Return on Capital Employed.
- Annual changes were most pronounced in 2023 — Return on Capital Employed slumped 619 bps — and 2024, when it soared 645 bps.
- Tracing GTBIF's Return on Capital Employed over 5 years: stood at 5.27% in 2022, then surged by 48 bps to 7.8% in 2023, then increased by 22 bps to 9.51% in 2024, then tumbled by 43 bps to 5.43% in 2025, then retreated by 4 bps to 5.2% in 2026.
- The last three Return on Capital Employed figures came in at 5.2% (Q1 2026), 5.43% (Q4 2025), and 7.47% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn | 6.60% |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn | 17.16% |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 6.07% |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 22.04% |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -0.29% |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 18.67% |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 5.52% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Green Thumb Industries | 1.65 Bn | 1.37 Bn | 137.87 Mn | 4.47% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.47% |
| Mar 31, 2026 | 5.20% |
| Dec 31, 2025 | 5.43% |
| Sep 30, 2025 | 7.47% |
| Jun 30, 2025 | 7.63% |
| Mar 31, 2025 | 8.29% |
| Dec 31, 2024 | 9.51% |
| Sep 30, 2024 | 9.20% |
| Jun 30, 2024 | 10.29% |
| Mar 31, 2024 | 8.99% |
| Dec 31, 2023 | 7.80% |
| Sep 30, 2023 | 3.81% |
| Jun 30, 2023 | 3.85% |
| Mar 31, 2023 | 4.86% |
| Dec 31, 2022 | 5.27% |
| Sep 30, 2022 | 9.49% |
| Jun 30, 2022 | 10.03% |
| Mar 31, 2022 | 9.85% |
| Dec 31, 2021 | 10.41% |
| Sep 30, 2021 | 11.50% |